WRVI Capital's Marks joins Atonarp board Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries with operations in Japan, the United States and India, has raised a US$50 million Series D financing to expand operations and products. The Series D financing was led by WRVI Capital. The [...]
Atonarp is a Japan-based developer and manufacturer of products such as molecular sensors and spectrometers for healthcare, pharmaceutical and semiconductor industries.